{"disease":{"id":"hypomethylating-agents","name":"hypomethylating agents"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04999943","title":"Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Affiliated Hospital to Academy of Military Medical Sciences","has_results":false},{"nct_id":"NCT04454580","title":"Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy","phase":"","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Ospedale Maggiore Di Trieste","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}